What Is Genetic Testing for Pregnancy?

Learn what genetic testing for pregnancy means in 2026, from NIPT to carrier screening. Understand your options and order a prenatal screening panel online.

Genetic testing for pregnancy refers to medical tests that analyze DNA from the mother and baby to assess the risk of certain chromosomal conditions, genetic disorders, or birth defects. In 2026, these tests are a routine part of prenatal care in the US, helping expectant parents make informed decisions. The most common type is non-invasive prenatal testing (NIPT), which uses cell-free DNA from a simple maternal blood draw and is recommended for all pregnancies regardless of age.

Types of Genetic Testing in Pregnancy

Prenatal genetic testing falls into two broad categories: screening tests and diagnostic tests. Screening tests estimate risk, while diagnostic tests provide a definitive answer. Below we explain the main types available in the US today.

Non-Invasive Prenatal Testing (NIPT)

NIPT, also called cell-free DNA screening, analyzes small fragments of fetal DNA circulating in the mother’s blood. It is highly accurate for detecting trisomies 21, 18, and 13, and can also screen for sex chromosome abnormalities. NIPT can be performed as early as 10 weeks into pregnancy. The fetal fraction—the percentage of cell-free DNA from the placenta—must be adequate (typically above 4%) for a reliable result. If the fetal fraction is too low, the lab may recommend a redraw.

Carrier Screening

Carrier screening is a blood or saliva test that identifies whether a parent carries a gene for a recessive condition such as cystic fibrosis, spinal muscular atrophy, or fragile X syndrome. It is often done before or early in pregnancy. If both parents are carriers of the same condition, there is a 25% chance the baby will be affected. Many US guidelines now recommend pan-ethnic carrier screening for a broad panel of disorders.

First-Trimester Screening (Combined Screening)

This test combines a blood draw (measuring PAPP-A and hCG) with a nuchal translucency ultrasound, typically done between 11 and 13 weeks. It screens for Down syndrome (trisomy 21) and trisomy 18. The results provide a risk estimate, not a diagnosis.

Quad Screen (Second-Trimester Screening)

The quad screen is a blood test performed between 15 and 22 weeks that measures four markers: AFP, hCG, estriol, and inhibin A. It screens for neural tube defects, Down syndrome, and trisomy 18. It is less accurate than NIPT but still commonly used when NIPT is not available or declined.

Integrated Screening

Integrated screening combines first-trimester and second-trimester results into a single risk estimate. It offers a higher detection rate than either test alone but requires two visits and waiting until the second trimester for final results.

Diagnostic Tests: Chorionic Villus Sampling (CVS) and Amniocentesis

These are invasive procedures reserved for when screening tests show an increased risk or when a known genetic condition runs in the family. CVS is performed at 10–13 weeks and samples placental tissue. Amniocentesis is done at 15–20 weeks and samples amniotic fluid. Both carry a small risk of miscarriage (roughly 1 in 300 to 1 in 500 for CVS, and about 1 in 500 to 1 in 1,000 for amniocentesis in experienced hands). A genetic counselor should discuss these risks and benefits before proceeding.

Key Differences Between Screening and Diagnostic Tests

What to Expect After Receiving Results

If a screening test suggests an increased risk, you will be offered a consultation with a genetic counselor. They will explain the results, discuss further testing options (such as CVS or amniocentesis), and help you weigh the next steps. It is important to remember that screening tests are not diagnostic—a “positive” screen does not mean the baby has a condition, only that further testing is warranted.

Additional Genetic Tests

• Prenatal paternity test: Can be performed via NIPT as early as 9 weeks, comparing fetal DNA with a paternal sample.
• Expanded carrier screening: Screens for hundreds of recessive conditions at once, often recommended by genetic counselors.
• Whole exome sequencing: Used in high-risk pregnancies when standard tests are inconclusive.

Making the Choice That’s Right for You

Every pregnancy is unique. Some parents want all available information; others prefer minimal testing. Discuss your preferences with your obstetrician or a genetic counselor. In 2026, most US insurers cover NIPT and carrier screening for all pregnancies, but it is wise to verify coverage beforehand.

If you are ready to take the next step, you can order a prenatal screening panel online and get your results quickly, typically within 7–10 business days. This comprehensive panel includes NIPT plus carrier screening for common conditions, giving you peace of mind early in your pregnancy.